

Tech on Drugs with Shai Shen-Orr
CytoReason
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials. It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
Episodes
Mentioned books

Feb 13, 2023 • 28min
Tech on Drugs - Episode 2 - Prof Yehuda Chowers
The doctor in the clinic must build on molecular features and the bioinformatician in the lab must build on data from the clinic. Prof. Yehuda Chowers, a leading gastroenterologist, has been harping on this point for years. It's a two-way street that will benefit both drug makers and drug consumers. In this episode of TOD, Chowers talks to host Shai Shen-Orr about immunogenicity, clinical trials, and population models.

Jan 16, 2023 • 28min
Tech on Drugs - Episode 1 - Ran Balicer
Our first episode features world renowned epidemiologist, Prof. Ran Balicer, Chief Innovation Officer at Clalit Health Services, Israel’s largest healthcare organization. We talked about the mining of real-world data and how it guides healthcare policy. The impact on Covid is pretty mind-boggling!

Jan 12, 2023 • 44sec
Introducing - Tech on Drugs
This is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials. In each episode, our host Prof. Shai Shen-Orr talks to world-leading scientists and healthcare executives about the future of pharma.


